In mammals, the first cell lineage specification is the formation of the trophectoderm (TE) and inner cell mass (ICM) during the blastocyst stage.^[@bib1]^ The TE forms tissues that make up the placenta, while the ICM gives rise to the embryo proper. Murine ICM cells proliferate rapidly between embryonic day 3.5 (E3.5) and E6.5 and then differentiate into three germ layers. As ICM cells give rise to the cells that make up an entire mammalian organism, the maintenance of genomic integrity within these cells is critical. Results from investigations using embryonic stem (ES) cells that are derived from the ICM, suggest two mechanisms help to support the genome integrity of ICM cells. Firstly, ES cells are sensitive to DNA damage and readily undergo apoptosis or differentiation in order to remove damaged cells from the pluripotent pool.^[@bib2],\ [@bib3]^ Secondly, ES cells possess a potent set of DNA repair machinery. Repair of double-strand breaks (DSBs), the most lethal form of DNA damage,^[@bib4]^ is rapidly induced in ES cells. Homologous recombination-mediated repair (HRR), which is the most accurate way to repair DSB,^[@bib5]^ is the predominate process involved in repairing DSB in ES cells.^[@bib6],\ [@bib7]^ The above studies underscore the importance of the DNA damage response (DDR) being set in motion efficiently following DNA damage within an ES cell. Knockout of the genes involved in the DDR leads to early embryonic lethality, which provides strong evidence of the critical roles played by DDR genes during early development. For example, a deficiency in *Rad51* leads to pre-implantational lethality,^[@bib8]^ while disruption of *Rad50*, *Atr* and *Brca1* reduces cell proliferation and causes abnormal embryonic development at the peri-implantation stage.^[@bib9],\ [@bib10],\ [@bib11]^ Therefore, investigation of the various proteins and other molecules involved in regulating DDR-related gene expression is crucial to obtaining a proper understanding of early embryonic development.

Cyclin-dependent kinase (Cdk) 12 is a protein kinase that belongs to the Cdk family.^[@bib12]^ By associating with cyclin K or cyclin L, Cdk12 executes diverse functions. For example, by interacting with cyclin L, Cdk12 regulates RNA splicing.^[@bib12]^ Furthermore, through an interaction with cyclin K, Cdk12 phosphorylates the C-terminal domain of RNA polymerase II, which facilitates elongation during transcription.^[@bib13]^ Finally, silencing of *Cdk12* results in the decreased expression of various DDR genes, such as *Brca1* and *Fanci*, which induces spontaneous DNA damage.^[@bib14]^

In mouse ES cells, *Cdk12* is required for self-renewal because knockdown of *Cdk12* leads to a reduced expression of a number of self-renewal related genes as well as an increased expression of a range of differentiation markers.^[@bib15]^ It has been speculated that DDR genes are downstream effectors of Cdk12 during the maintenance of pluripotency among ES cells because genomic stability is linked to mouse ES cell differentiation.^[@bib15],\ [@bib16]^ In human cancers, perturbation and/or mutation of *Cdk12* has been implicated in pathogenesis and drug resistance. *Cdk12* can be co-amplified with *ERBB2* or may be fused with *ERBB2* in breast cancer^[@bib17]^ and gastric cancer.^[@bib18]^ Furthermore, *Cdk12* has been identified as a candidate tumor suppressor gene in ovarian cancer.^[@bib19],\ [@bib20]^ Those *Cdk12* mutations associated with ovarian cancer show low levels of kinase activity, which leads to a downregulation of the DDR genes; this was found to sensitize cells to DNA damage drugs in HGS-OvCa patient samples.^[@bib21],\ [@bib22]^

The expression of Cdk12 protein is abundant in mouse ES cells and it then decreases as cell differentiation begins.^[@bib15]^ *Cdk12* mRNA has been detected in whole embryos at E6.5 and is at a high level in the primitive streak at E7.5.^[@bib23]^ Based on the expression pattern and biological functions of Cdk12, it is expected that Cdk12 has an important role in maintaining genomic stability during early embryonic development. To investigate the role of Cdk12 during embryonic development, *Cdk12* knockout mice were generated. *Cdk12* knockout in mice was found to be fatal during the peri-implantation stage. In addition, *Cdk12*^*−/−*^ blastocysts fail to undergo ICM outgrowth in *in vitro* culture because of an increased level of apoptosis. The expression of DDR genes is lowered and there is an increase in the number of DSBs that can be detected in *Cdk12*^*−/−*^ embryonic cells. These findings identify *Cdk12* as a critical factor that is involved in maintaining genomic stability during the early embryonic development in mice.

Results
=======

Generation of *Cdk12* knockout mice
-----------------------------------

To investigate biological role of *Cdk12* in mouse embryonic development, *Cdk12* knockout mice were generated from *Cdk12*^*fx/fx*^ mice by mating them with *Protamin-Cre* transgenic mice expressing the Cre recombinase during spermatogenesis.^[@bib23],\ [@bib24]^ Exons 3 and 4 of *Cdk12* were deleted by Cre-mediated recombination ([Figure 1A](#fig1){ref-type="fig"}) and the knockout allele is predicted to give rise to a prematurely terminated Cdk12 protein lacking the kinase domain. Germline transmission of the knockout allele and the presence of truncated mRNA were verified by nested-PCR and RT-PCR ([Figures 1B and C](#fig1){ref-type="fig"}). The *Cdk12*^*fx/−*^ mice are viable and fertile. However, when *Cdk12*^*fx/−*^ mice are crossed with each other, they do not give rise to viable *Cdk12*^*−/−*^ neonates. No postnatal *Cdk12*^*−/−*^ mice were found among 108 live-born mice from the intercross ([Table 1](#tbl1){ref-type="table"}), which suggests that a homozygous deficiency in *Cdk12* leads to embryonic lethality. To detect the exact stage at which *Cdk12*^*−/−*^ mice exhibit developmental failure, embryos were collected at various gestation time points and it was found that there were no surviving *Cdk12*^*−/−*^ embryos at E14.5, E7.5 or E6.5. Furthermore, the number of empty decidua was found to increase after E6.5 and to match the expected number of *Cdk12*^*−/−*^ embryos by Mendel\'s law ([Table 1](#tbl1){ref-type="table"}). Upon examination of E3.5 embryos, we found that the number of *Cdk12*^*−/−*^ embryos present were in agreement with Mendel\'s ratio ([Table 1](#tbl1){ref-type="table"}), and that the morphology of the *Cdk12*^*−/−*^ embryos was indistinguishable from that of *Cdk12*^*fx/−*^and *Cdk12*^*fx/fx*^ embryos ([Figure 2Aa--c](#fig2){ref-type="fig"}). These findings indicate that *Cdk12* deficiency seems to cause embryonic lethality immediately after implantation.

Expression and cellular location of the Cdk12 protein in pre-implantation embryos
---------------------------------------------------------------------------------

Our recent study has demonstrates that *Cdk12* mRNA is detected ubiquitously from E6.5 to E9.5 by *in situ* hybridization.^[@bib23]^ Since we have discovered that *Cdk12* is required for the embryonic development before E6.5, we next examined the expression pattern of Cdk12 protein during the early embryonic stages; this was done by immunofluorescence staining. Cdk12 is detected in oocytes and expression continues from the two-cell stage to the blastocyst stage at E3.5 ([Figure 1Df--j](#fig1){ref-type="fig"}). At the blastocyst stage, Cdk12 can be detected in both ICM and TE cells ([Figure 1Dj](#fig1){ref-type="fig"}). Cdk12 protein is evenly distributed across the cytoplasm and nucleus from the two-cell stage to the morula stage ([Figure 1E](#fig1){ref-type="fig"}). Strikingly, a greater amount of Cdk12 protein is present in the nucleus at E3.5 stage than at morula and earlier stages ([Figure 1F](#fig1){ref-type="fig"}). As Cdk12 functions in the nucleus,^[@bib12],\ [@bib13]^ these results indicate that Cdk12, while present in the earlier stages of embryo development, may only become fully activated after E3.5. However, because Cdk12 can be detected in oocytes ([Figure 1Df](#fig1){ref-type="fig"}), we tested whether a maternal source of Cdk12 protein is able to support embryo development before E3.5. To investigate this possibility, *Zp3-Cre* transgenic mice, which exhibit Cre activity during oogenesis,^[@bib25]^ were used to generate *Cdk12* knockout oocytes. The morphology of the maternally *Cdk12*-null (*Cdk12*^*mat-/fx*^) embryos is indistinguishable from *Cdk12*^*+/fx*^ embryos at E3.5 ([Figure 1G](#fig1){ref-type="fig"}), and *Cdk12*^*mat-/fx*^pups are viable ([Table 2](#tbl2){ref-type="table"}). These results show that maternal Cdk12 protein is not essential for mouse embryonic development before E3.5.

Cultured *Cdk12*^*−/−*^ blastocysts exhibit impaired ICM and TG cell outgrowth
------------------------------------------------------------------------------

Based on the fact that *Cdk12*^*−/−*^ embryos exhibit peri-implantation lethality, it is difficult to study the molecular mechanism underlying the lethality *in vivo*. As a result of this problem, we used the *in vitro* culture of blastocysts as an alternative approach. E3.5 blastocysts from intercrosses of *Cdk12*^*fx/−*^ mice were isolated and cultured for 4 days *in vitro* (DIV). Both *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^embryos break out from the zona pellucida and possess an enlarged blastocyst cavity at 1 DIV ([Figure 2Ad and e](#fig2){ref-type="fig"}). They then attach to the culture plate and initiate outgrowth at 2 DIV ([Figure 2Ag and h](#fig2){ref-type="fig"}). The ICM cells expand as a round-shape aggregate on top of the trophoblast giant (TG) cell monolayer at 3 DIV ([Figure 2Aj and k](#fig2){ref-type="fig"}). ICM and TG cells keep expanding during 4 DIV ([Figure 2Am and n](#fig2){ref-type="fig"}). It was found that the morphology of the *Cdk12*^*−/−*^ embryos is similar to that of the *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^ embryos at 0 and 1 DIV ([Figure 2Ac and f](#fig2){ref-type="fig"}). Furthermore, the attachment of *Cdk12*^*−/−*^ embryos to the culture plate, and the outgrowth areas from ICM and TG cells are also similar to those with *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^ embryos during 2 DIV ([Figures 2Ai, B and C](#fig2){ref-type="fig"}). However, Cdk12-deficient ICM cells exhibit impaired expansion and the monolayer area of TG cells does not increase during 3 and 4 DIV ([Figures 2Al and o, B and C](#fig2){ref-type="fig"}). We further characterized remaining cells at 4 DIV and Cdk12 expression during outgrowth of *Cdk12*^*−/−*^ embryos was investigated by immunostaining. In *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^ embryos, Cdk12 staining is distributed generally across both ICM and TG cells with a stronger signal in the nucleus than in the cytoplasm ([Figure 2Da and b](#fig2){ref-type="fig"}). ICM cells were detected using Oct4 expression ([Figure 2Dd and e](#fig2){ref-type="fig"}). When the *Cdk12*^*−/−*^ embryos were examined, no Cdk12 staining signal could be detected, and very few cells display any significant Oct4 staining ([Figure 2Df](#fig2){ref-type="fig"}). When taken together, these findings indicate that *Cdk12* deficiency leads to impaired ICM and TG cell outgrowth.

*Cdk12* deficiency leads to apoptosis within the ICM
----------------------------------------------------

To analyze the underlying mechanisms associated with the failed outgrowth of *Cdk12*^*−/−*^ embryos, we examined whether Cdk12 is required for lineage specification, cell proliferation and/or the prevention of apoptosis. E3.5 blastocysts were collected and then probed with Oct4 and Cdx2 antibodies to identify ICM and TE lineage cells, respectively. Oct4 is present in all blastomeres and Cdx2 is restricted to the outside blastomeres at E3.5.^[@bib26]^ The number of ICM (Oct4^+^/Cdx2^−^) and TE cells (Cdx2^+^) were counted ([Figure 3Aj--l](#fig3){ref-type="fig"}) and no difference was found between the cell numbers of the ICM lineage compared with the TE lineage when *Cdk12*^*fx/fx*^, *Cdk12*^*fx/−*^ and *Cdk12*^*−/−*^ embryos were compared ([Figur 3B](#fig3){ref-type="fig"}). This indicates that *Cdk12* is not required for specifying that the ICM and TE lineages at E3.5. We further examined whether there are proliferation defects in *Cdk12*^*−/−*^ embryos or perhaps whether there is an abnormal apoptosis occurring in *Cdk12*^*−/−*^ embryos. Cell proliferation was measured using a 45-min EdU incorporation assay and apoptotic cells were detected by TUNEL assay. The ratio of EdU positive cells in control and *Cdk12*^*−/−*^ embryos is similar at 0 and 1 DIV ([Figures 3C and D](#fig3){ref-type="fig"}). No TUNEL positive cells are observed in *Cdk12*^*fx/fx*^, *Cdk12*^*fx/−*^ or *Cdk12*^*−/−*^ embryos at 0 DIV and 1 DIV ([Figure 3Ea--c and g--i](#fig3){ref-type="fig"}). At 2 DIV, however, there were numerous TUNEL positive cells present among the ICM cells of *Cdk12*^*−/−*^ embryos ([Figures 3Eo and F](#fig3){ref-type="fig"}). The ratio of TUNEL positive cells among the TG cells of *Cdk12*^*fx/fx*^, *Cdk12*^*fx/−*^ and *Cdk12*^*−/−*^ embryos were found to be similar at 2 DIV ([Figure 3F](#fig3){ref-type="fig"}). These findings indicate that *Cdk12* deficiency induces apoptosis within the ICM at 2 DIV. To further verify the importance of *Cdk12* to maintaining ICM viability, *Sox2-Cre* transgenic mice that express *Cre* specifically in the ICM from E3.5 onwards were crossed with *Cdk12*^*fx/fx*^ mice.^[@bib27]^ No *Sox2-Cre*^*+/0*^*; Cdk12*^*−/−*^ embryos can be detected when embryos were examined from E6.5 to E13.5, although numerous empty decidua could be observed ([Table 3](#tbl3){ref-type="table"}). These findings indicate that Cdk12 is required to be expressed in the ICM by E6.5 to allow cell survival.

*Cdk12* deficiency decreases the expression of DDR genes
--------------------------------------------------------

As Cdk12 is involved in the maintenance of genomic stability via regulation of expression of DDR genes,^[@bib14]^ we investigated whether apoptosis in *Cdk12*-deficient embryos is a result of improper expression of DDR genes in response to DNA damage. As increase in apoptotic cells can be detected in *Cdk12*^*−/−*^ embryos at 2 DIV ([Figure 3Eo](#fig3){ref-type="fig"}), it is expected that *Cdk12* deficiency-mediated cellular changes ought to be able to be detected at 1 DIV. DSBs are the most lethal form of DNA damage,^[@bib4]^ and 53BP1 foci can be used as a marker for the presence of DSBs.^[@bib28]^ It was found that there were few cells with five or more 53BP1 foci per nucleus among ICM cells (1.32%±1.32% and 3.19%±1.48% in *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^ embryos, respectively) and TE cells (3.41%±3.41% and 4.70%±2.04% in *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^ embryos, respectively) of *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/*−^ embryos at 1 DIV ([Figures 4Aa and b, B and C](#fig4){ref-type="fig"}). Among *Cdk12*^*−/−*^ embryos, cells with five or more 53BP1 foci per nucleus showed a significantly increased trend of 25.50%±5.52% and 31.04%±9.45% among ICM and TE cells, respectively ([Figures 4Ac, B and C](#fig4){ref-type="fig"}). In accordance with increased number of DSBs, it was possible to detect lower levels of expression of various DDR genes, namely *Atr*, *Brca1*, *Fancd2* and *Fanci*, in *Cdk12*^*−/−*^ embryos at 1 IDV ([Figure 4D](#fig4){ref-type="fig"}). The mRNA level of *Cyclin K* shows a similar pattern of expression across all embryos regardless of their genotype. We also examined the expression of DDR genes at the morula stage, a time point where Cdk12 is not functional. The mRNA level of *Atr*, *Brca1*, *Fancd2*, *Fanci* and *Cyclin K* shows a similar pattern of expression across all embryos regardless of their genotype ([Figure 4E](#fig4){ref-type="fig"}). These findings show that *Cdk12* deficiency reduces the expression of DDR genes, resulting in a failure to repair DNA damage in these cells.

Discussion
==========

In this study, we have demonstrated the importance of Cdk12 protein to mouse embryonic development. Depletion of its activity in knockout mice or *Sox2-Cre*-mediated conditional knockout mice delivers no embryos that survived beyond E6.5 ([Tables 1](#tbl1){ref-type="table"} and [3](#tbl3){ref-type="table"}). However, E3.5 embryos were found to be morphologically normal, which points toward a requirement for Cdk12 activity that starts after E3.5. The fact that depletion of maternal-derived Cdk12 allows the development of normal pups further supports this view ([Table 2](#tbl2){ref-type="table"}). An interesting correlation is that the presence of Cdk12 protein in the nucleus becomes more apparent after E3.5 ([Figure 1](#fig1){ref-type="fig"}), which is a prerequisite for exerting its known functions regarding transcription and splicing. Using cultured embryos, we discovered that the expression levels of four DDR genes were reduced to below 50% of that found in *Cdk12*^*fx/fx*^ or *Cdk12*^*fx/−*^ embryos when Cdk12 was absent ([Figure 4D](#fig4){ref-type="fig"}). Reduced expression of these genes in combination will lead to a greater number of DSBs in the genome of the mutant ICM and TE cells, which would subsequently trigger apoptosis of the ICM cells and senescence of the TE cells ([Figures 2A](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"}).

*Cdk12* deficiency leads to an arrest of embryonic development right after implantation based on the fact that no *Cdk12*^*−/−*^ embryos can be identified at E6.5 and that empty decidua increase after E6.5. This observation is further supported by our blastocyst cultured *in vitro* results. At the suspension stage, namely 0 and 1 DIV, the morphology, cell lineage specification and rates of cell proliferation and apoptosis are similar for all embryos, *Cdk12*^*−/−*^, *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^. After embryo attachment at 2 DIV, ICM cells of *Cdk12*^*−/−*^ embryos are not able to outgrow because of the increase in apoptosis of these cells ([Figure 5a](#fig5){ref-type="fig"}). Although at 2 DIV the number of apoptotic cells is significantly increased only among the ICM cells of *Cdk12*^*−/−*^ embryos and this does not occur among the TG cells of *Cdk12*^*−/−*^ embryos, a greater number of DNA DSBs can be detected in both ICM cells as well as TE cells of *Cdk12*^*−/−*^ embryos at 1 DIV. The discrepancy can be explained by a differential response to DNA damage between ICM and TE cells. At 2 DIV, *Cdk12*^*−/−*^ ICM cells undergo apoptosis due to accumulated DNA damage; however, TE cells are induced to differentiate into TG cells which are able to evade DNA damage-induced apoptosis and rather undergo senescence via an elevation of p21 expression.^[@bib29],\ [@bib30]^

During early embryonic development, cell cycle progression is rapid and DNA replication is prominent. The integrity of the genome is thus constantly at risk due to the mistakes intrinsic to DNA replication.^[@bib31]^ Highly efficient DNA repair is mediated by homologous recombination and this is crucial for the proper development of the organism during this period. For example, *Atr*^*−/−*^ and *Brca1*^*−/−*^ embryos display growth retardation after implantation, and *in vitro* culture of their blastocysts show impaired ICM outgrowth.^[@bib10],\ [@bib11]^ Our findings that there are many more DSBs in cultured embryos after loss of Cdk12 activity after just 1 DIV ([Figure 4A](#fig4){ref-type="fig"}) and that no *Cdk12*^*−/−*^ embryos survive beyond E6.5 further supports the importance of DNA repair during early embryonic development. In addition, the similarity between the phenotypes of mutant embryos and cultured blastocysts of *Cdk12*^*−/−*^, *Atr*^*−/−*^ and *Brca1*^*−/−*^ mice^[@bib10],\ [@bib11]^ is consistent with Cdk12 affecting the expression of *Atr* and *Brca1*. Although mRNAs encoding *Atr*, *Brca1*, *Fanci* and *Fancd2* are still present in *Cdk12*^*−/−*^ embryos, our results show a parallel and significant decrease in the expression of these four genes when *Cdk12*-deficient embryos are investigated and this decrease is likely to be sufficient to disrupt DNA damage repair ([Figure 5b](#fig5){ref-type="fig"}).

Interestingly, we found that *Cdk12*^*−/−*^ embryos develop normally up to the blastocyst stage. We originally considered whether maternal Cdk12 protein may allow normal development before E3.5, as Cdk12 protein can be detected in oocytes and fertilized eggs. Thus, it was a surprise when we found that maternal-null blastocysts are morphologically normal and maternal-null mouse embryos are viable. It is likely that there are other proteins regulating expression of the DDR genes and maintaining efficient DNA damage repair before E3.5. Alternatively, the expression of maternal DDR gene products is able to repair DNA damage and thus supports embryonic development until E3.5. It has been shown that embryos deficient of important DDR genes still develop normally up to peri-implantation stage,^[@bib8],\ [@bib9],\ [@bib10],\ [@bib11]^ and maternal Pms2 and Bcas2 proteins are able to maintain integrity of genome before implantation.^[@bib32],\ [@bib33]^

We noted that there is conspicuous nuclear localization of Cdk12 at E3.5, but not at the morula stage, which suggests that Cdk12 may not be active in the cell nucleus with respect to transcription and splicing until E3.5. Measurement of DDR genes\' transcripts supports this line of reasoning as expression of DDR genes was decreased in *Cdk12*^*−/−*^ embryos compared with that in *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^embryos at 1 DIV but not at morula stage ([Figure 4D and E](#fig4){ref-type="fig"}). One molecule that may facilitate the translocation of Cdk12 from cytoplasm to the nucleus is cyclin K, as the activation of Cdk12 depends on an association with Cyclin K, and *Cyclin K* knockout mice exhibit similar embryonic lethality phenotype to that of *Cdk12*^*−/−*^ mice.^[@bib14]^ Exploring cyclin K expression and its cellular localization during morula and blastocyst stages will be the first step in exploring this possibility in the future.

Dai *et al.*^[@bib15]^ previously reported that the knockdown of Cdk12 in mouse ES cells results in a loss of expression of the pluripotent makers, Oct4 and Sox2, and instead allows the expression of differentiation markers. Here, we have found that cultured ICM cells that are deficient in Cdk12 still express Oct4 even though they are undergoing apoptosis ([Figure 3E](#fig3){ref-type="fig"}). This discrepancy may reflect intrinsic differences between ICM cells and cultured ES cells. Alternatively, Cdk13, a protein with many properties identical to Cdk12,^[@bib14],\ [@bib15],\ [@bib23],\ [@bib34]^ may be able to compensate for the lack of Cdk12 and bring about regulation of the expression of the relevant self-renewal markers and differentiation markers.

Our results reveal that a deficiency in *Cdk12* increases genomic instability and decreases the expression of DDR genes *in vivo*. These findings shed a new light on the important role that Cdk12 plays in embryonic development and possibly also carcinogenesis. In support of our hypothesis, recent studies have demonstrated that expression of Cdk12 is perturbed in several cancers, including breast cancer,^[@bib35]^ gastric cancer^[@bib18]^ and ovarian cancer.^[@bib21],\ [@bib22],\ [@bib36]^ Thus our conditional knockout mouse model may also be useful as a means of clarifying the role of Cdk12 in cancer.

Materials and methods
=====================

Mice, genotyping, RT-PCR and real-time PCR
------------------------------------------

Adult C57BL/6J mice were obtained from the National Laboratory Animal Center (Taipei, Taiwan). All mice were handled according to the University guidelines and all experiments were approved by the National Yang-Ming University Animal Care and Use Committee. For the timed pregnancies, mice were set up in the late afternoon and when plugs were detected next morning, this stage of the mouse embryos was designated as E0.5. Generation of *Cdk12*^*fx/fx*^ mice has be described previously.^[@bib23]^ To generate the maternal deleted embryos, *Zp3-Cre*^*+/0*^*; Cdk12*^*fx/+*^ female mice were mated with *Cdk12*^*fx/fx*^ male mice; one-half of their progeny were maternal *Cdk12* null.^[@bib25]^ Genotyping of the postnatal mice was performed by PCR using DNA extracted from their tails. Blastocysts were genotyped by nested-PCR. After the embryos were isolated and outgrowth assays or immunostaining performed, the blastocysts were dissolved in DNA lysis buffer containing 50 mM Tris-HCl, pH 8.0, 0.5% Triton X-100 and 200 *μ*g/ml proteinase K. The embryos were digested at 55 °C for 2 h and then the proteinase K was inactivated at 95 °C for 5 min.

Total RNA from E14.5 embryos was extracted using the RNeasy Plus Mini kit (Qiagen, Valencia, CA, USA). The RNA was used for cDNA synthesis with the SuperScript reverse transcriptase III (Invitrogen, Carlsbad, CA, USA). Total RNA of blastocysts and morula was purified and reverse transcribed to cDNA using a TaqMan Gene Expression Cells-to-CT Kit (Ambion, Austin, TX, USA). cDNA was pre-amplified with a specific set of primers using TaqMan PreAmp Master Mix kit (Applied Biosystems, Foster, CA, USA) and used for real-time PCR on an ABI StepOne real-time PCR machine (Applied Biosystems). Samples were assayed in triplicate and normalized against TATA-box binding protein. The sequences of the primers used for the PCR and real-time PCR reactions are provided in [Table 4](#tbl4){ref-type="table"}.

Blastocyst isolation and *in vitro* blastocyst culture
------------------------------------------------------

Blastocysts were flushed out from the uterus of pregnant mice at E3.5. To culture the blastocysts, the embryos were transferred to 0.2% gelatin-coated tissue culture plates with mouse ES medium (DMEM, 0.1 mM nonessential amino acids, 0.1 mM sodium pyruvate, 2 mM GlutaMAX-I (all from Gibco, Billings, MT, USA), 15% ES cell qualified FBS (Hyclone, South Logan, Utah, USA), 0.1 mM β-mercaptoethanol (Sigma, St Louis, MI, USA), and 1000 unit/ml leukemia inhibitory factor (Chemicon, Billerica, MA, USA)). Embryos were cultured in the presence of 5% CO~2~ at 37 °C and photographed daily using a microscope (ZEISS Axio Observer A1, Jena, Germany).

Immunostaining, DNA synthesis assay and apoptosis assay
-------------------------------------------------------

Embryos at the indicated stage were fixed in 4% paraformaldehyde in PBS at room temperature for 20 min. The fixed embryos were washed with PBS and then permeabilized with 0.2% Triton X-100 in PBS at room temperature for 20 min. Blocking was performed with PBS containing 5% goat serum and 0.2% Triton X-100 at room temperature for 1 h. Immunostaining was carried out overnight at 4 °C in the presence of a primary antibody. The primary antibodies used in this study were rabbit anti-Cdk12 antibody (1:500),^[@bib12]^ mouse anti-Cdx2 antibody (Cdx2-88, 1:500, BioGenex, San Ramon, CA, USA), rabbit anti-Oct4 antibody (H-134, 1:500, Santa Cruz, CA, USA) and rabbit anti-53BP1 antibody (1:500, Santa Cruz). After washing with PBS three times, embryos were incubated with appropriate secondary antibodies conjugated with TRITC, Alexa 488 or Alexa 630 at room temperature for 1 h. The DNA was then stained with 1 *μ*g/ml DAPI for 30 min. DNA synthesis was measured by EdU incorporation. Embryos were labeled with 10 *μ*M EdU in mouse ES medium for 45 min and then labeling was detected using a Click-iT EdU Imaging kit (Invitrogen) according to the manufacturer\'s instructions. The apoptosis assay was performed by TUNEL staining using an *In Situ* Cell Death Detection Kit (Roche, Indianapolis, IN, USA). Images were taken every 3 *μ*m throughout the embryo by confocal microscopy (Olympus FV10i, Tokyo, Japan and ZEISS LSM700).
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![Generation of *Cdk12* knockout mice. (**A**) A schematic diagram of *Cdk12* floxed and knockout alleles is shown. Arrows represent the locations of the genotyping primers. (**B**) E3.5 blastocysts were collected after the *Cdk12*^*fx/−*^ intercross and genotyped by nested-PCR. The bands representing floxed and knockout alleles are 563 and 498 bp, respectively. (**C**) mRNA was extracted from *Cdk12*^*fx/fx*^ and *Cdk12*^*fx/−*^E14.5 embryos and transcripts derived from the floxed and knockout *Cdk12* allele were detected by RT-PCR. The bands representing the normal transcript and the knockout transcript are 660 and 343 bp, respectively. (**D**) Oocyte and embryos were examined using Cdk12 antibody. Nuclei are indicated by DAPI staining (**E** and **F**) Intensity profiles of Cdk12 expression in the cytoplasm and the nucleus along the indicated lines of interest were obtained by confocal sectioned images that reveal the cellular localization of Cdk12 protein at morula stage and in E3.5 embryos. (**G**) Photographs of E3.5 embryos derived from mating between *Zp3-Cre*^*+/0*^; *Cdk12*^*fx/+*^ female mice with *Cdk12*^*fx/fx*^ male mice. Scale bar, 20 *μ*m](cdd2015157f1){#fig1}

![*Cdk12* deficiency results in impaired outgrowth of the blastocyst. (**A**) Blastocysts were collected by *Cdk12*^*fx/−*^ intercrossing and cultured *in vitro* for 4 days. At the indicated day, embryos were photographed under bright-field conditions. The surface areas of the ICM (**B**) and TG (**C**) outgrowth at daily intervals are showed as mean±S.E.M. \**P*\<0.05, by one-way ANOVA. *Cdk12*^*fx/fx*^, *n*=10; *Cdk12*^*fx/−*^, *n*=21; *Cdk12*^*−/−*^, *n*=8. (**D**) E3.5 embryos were cultured *in vitro* for 4 days and then immunostained with anti-Cdk12 and anti-Oct4 antibodies. Nuclei are marked by DAPI staining. Scale bar, 50 *μ*m](cdd2015157f2){#fig2}

![*Cdk12* deficiency induces apoptosis of ICM cells. (**A**) E3.5 embryos were collected and immunostained with anti-Oct4 and anti-Cdx2 antibodies. Nuclei were indicated by DAPI staining. Individual confocal sections of whole-mount embryos are shown. (**B**) The cell numbers of ICM and TE lineages in E3.5 embryos were quantified. *Cdk12*^*fx/fx*^, *n*=5; *Cdk12*^*fx/−*^, *n*=8; *Cdk12*^*−/−*^, *n*=4. (**C**) Cell proliferation of 0 and 1 DIV embryos was measured using a 45-min EdU incorporation assay. (**D**) Quantitative results of (**C**). At 0 DIV, control, *n*=8; *Cdk12*^*−/−*^, *n*=3. At 1 DIV, control, *n*=11; *Cdk12*^*−/−*^, *n*=3. (**E**) Apoptotic cells were detected by TUNEL assay at 0, 1 and 2 DIV. (**F**) Quantitative results of (**E**) at 2 DIV. *Cdk12*^*fx/fx*^, *n*=3; *Cdk12*^*fx/*−^, *n*=5; *Cdk12*^*−/−*^, *n*=3. Results are shown as mean±S.E.M. \**P*\<0.05, by one-way ANOVA. Scale bar, 20 *μ*m](cdd2015157f3){#fig3}

![*Cdk12* deficiency leads to an increase in the number of DSBs and reduces the expression of DDR genes. (**A**) Blastocysts were cultured for 1 day and then immunostained with anti-53BP1 and anti-Oct4 antibodies. Nuclei were marked by DAPI staining. The percentage of cell numbers with 53BP1 foci in ICM cells (**B**) and TE cells (**C**) were quantified. ICM and TE cells were defined as Oct4^+^ and Oct4^−^, respectively. *Cdk12*^*fx/fx*^, *n*=4; *Cdk12*^*fx/−*^, *n*=6; *Cdk12*^*−/−*^, *n*=5. Relative mRNA levels of the indicated genes were determined by real-time PCR at 1 DIV ((**D**), *Cdk12*^*fx/fx*^, *n*=4; *Cdk12*^*fx/−*^, *n*=8; *Cdk12*^*−/−*^, *n*=5) and morula stage ((**E**), *Cdk12*^*fx/fx*^, *n*=6; *Cdk12*^*fx/*−^, *n*=11; *Cdk12*^*−/−*^, *n*=4). Results are shown as mean±S.E.M. \**P*\<0.05, by one-way ANOVA](cdd2015157f4){#fig4}

![A schematic diagram demonstrates that Cdk12 is required to sustain the viability of the ICM and TE through the maintenance of genome integrity. (**a**) In the absence of active Cdk12, blastocysts failed to outgrow because of an increase in DNA DSBs in ICM and TE cells. (**b**) Cdk12 has a crucial role in the regulation of expression of DDR genes that preserve the replication fork structure and repair lesions. In the absence of Cdk12, the fork collapses and as a consequence of this DSBs occur](cdd2015157f5){#fig5}

###### Genotypes of offspring from the *Cdk12* ^*fx/--*^ intercrosses

  **Stage**   ***Cdk12***^***fx/fx***^ **(expected: 25%)**   ***Cdk12***^***fx/--***^ **(expected: 50%)**    ***Cdk12***^***--/--***^ **(expected: 25%)**   **Empty decidua**
  ----------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- -------------------
  E3.5        28 (29.1%)                                     46 (47.9%)                                                       22 (22.9%)                           ---
  E6.5        6 (27.3%)                                      16 (72.7%)                                                           0                                 6
  E7.5        12 (27.3%)                                     32 (72.7%)                                                           0                                24
  E14.5       5 (31.3%)                                      11 (68.8%)                                                           0                                 0
  Postnatal   43 (39.8%)                                     65 (60.2%)                                                           0                                ---

###### Genotypes of the offspring from *Zp3-Cre* ^*+/0*^ *; Cdk12* ^*fx/+*^ × *Cdk12* ^*fx/fx*^ crosses

  **Stage**   ***Cdk12***^***mat-/fx***^ **(expected: 50%)**   ***Cdk12***^***+/fx***^ **(expected: 50%)**
  ----------- ------------------------------------------------ ---------------------------------------------
  E3.5        2 (50%)                                          2 (50%)
  Postnatal   24 (45.3%)                                       29 (54.7%)

###### Genotypes of the offspring from *Sox2-Cre*^*+/0*^; *Cdk12*^*+/--*^ × *Cdk12*^*fx/fx*^ crosses

  **Stage**   ***Cdk12***^***+/fx***^ **(expected: 25%)**   ***Cdk12***^***−/fx***^ **(expected: 25%)**   ***Sox2-Cre***^***+/o***^***; Cdk12***^***+/−***^ **(expected: 25%)**   ***Sox2-Cre***^***+/o***^***; Cdk12***^*−/−*^ **(expected: 25%)**   **Empty decidua**
  ----------- --------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------- ------------------------------------------------------------------- -------------------
  E6.5        3 (27.3%)                                     3 (27.3%)                                     5 (45.5%)                                                               0                                                                   5
  E7.5        13 (30.2%)                                    14 (32.6%)                                    16 (37.2%)                                                              0                                                                   13
  E8.5        5 (29.4%)                                     7 (41.2%)                                     5 (29.4%)                                                               0                                                                   9
  E9.5        14 (36.8%)                                    13 (34.2%)                                    11 (28.9%)                                                              0                                                                   11
  E10.5       4 (36.4%)                                     4 (36.4%)                                     3 (27.3%)                                                               0                                                                   6
  E13.5       3 (37.5%)                                     2 (25%)                                       3 (37.5%)                                                               0                                                                   0
  P0          4 (36.4%)                                     3 (27.3%)                                     4 (36.4%)                                                               0                                                                   ---

###### Primers used for PCR, RT-PCR and real-time PCR

  **Primer**                  **Sequence**                                                                          **Probe (Roche)**
  --------------------------- ------------------------------------------------------------------------------------- -------------------
  *Genotyping*                                                                                                      
   a                          5′-CTTCCTGCCTCCTCTTCATCATCAGGTATTG-3′ (NT165773.2)[a](#t4-fn1){ref-type="fn"}          
   b                          5′-GTTCAGACAGTGTCAGACCACCTGGAGAAGC-3′ (NT165773.2)[a](#t4-fn1){ref-type="fn"}          
   c                          5′-CCTCTGACCTCCCAATGTGTGCATGACAC-3′ (NT165773.2)[a](#t4-fn1){ref-type="fn"}            
   d                          5′-GTCCAGCCGAACCTTCTTCAGAGCTACTAG-3′ (NT165773.2)[a](#t4-fn1){ref-type="fn"}           
                                                                                                                     
  *Transcription detection*                                                                                         
   Cdk12                      \(F\) 5′-CAGCTACTACCCCTCCACCTCAGACAC-3′ (NM_026952.2)[a](#t4-fn1){ref-type="fn"}       
                              \(R\) 5′-GTCCAGCCGAACCTTCTTCAGAGCTACTAG-3′ (NM_026952.2)[a](#t4-fn1){ref-type="fn"}    
                                                                                                                     
  *Real-time PCR*                                                                                                   
   Atr                        \(F\) 5′-CCCATGCGAATCATGACC-3′                                                        104
                              \(R\) 5′-ACATCATCGAAGCCTGCAA-3′                                                        
   Brca1                      \(F\) 5′-ACGAGTCAGGGATGGGAAG-3′                                                       46
                              \(R\) 5′-CCTGAGAGGGGGAGTTTCTC-3′                                                       
   Cyclin K                   \(F\) 5′-TCCCAAACTTGAGGCTACTCAC-3′                                                    67
                              \(R\) 5′-GAGGCTTCCGGTCTGGAG-3′                                                         
   Fancd2                     \(F\) 5′-AACGAAGGGAAGCAACTGG-3′                                                       29
                              \(R\) 5′-CTAGCCGACGTCTTTTGGAA-3′                                                       
   Fanci                      \(F\) 5′-CACCCTAACAGCATTCGTCA-3′                                                      6
                              \(R\) 5′-CGACAGCTTCACCAGTTTTTC-3′                                                      
   Tbp                        \(F\) 5′-GGCGGTTTGGCTAGGTTT-3′                                                        104
                              \(R\) 5′-GGGTTATCTTCACACACCATGA-3′                                                     

Accession number of the reference sequence
